Decatur Capital Management, Inc. Merck & Co., Inc. Transaction History

Decatur Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $6.52 Million - $7.68 Million	-94,648 Closed	0 $0
Q4 2020 Jan 28, 2021	SELL	$71.77 - $79.65 $148,922 - $165,273	-2,075 Reduced 2.15%	94,648 $7.74 Million
Q3 2020 Nov 03, 2020	BUY	$73.18 - $82.95 $1.3 Million - $1.47 Million	17,780 Added 22.52%	96,723 $8.02 Million
Q2 2020 Aug 04, 2020	BUY	$70.42 - $80.13 $492 - $560	7 Added 0.01%	78,943 $6.11 Million
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $1.28 Million - $1.77 Million	-20,150 Reduced 20.34%	78,936 $6.07 Million
Q4 2019 Jan 21, 2020	BUY	$77.58 - $87.54 $7.69 Million - $8.67 Million	99,086 New	99,086 $9.01 Million

3,821

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Decatur Capital Management, Inc. with notifications on news.